Results 151 to 160 of about 27,193 (247)

Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon‐Like Peptide‐1 Receptor Agonists in Type 2 Diabetes

United European Gastroenterology Journal, Volume 14, Issue 5, June 2026.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely prescribed for type 2 diabetes mellitus (T2DM) because of their benefits in glycemic control, weight reduction, and cardiovascular outcomes. This study evaluated the risk of gallbladder disease among diabetic patients treated with GLP‐1 RAs.
Mohamed H. Eldesouki, Omar Alkasabrah, Mohammed Kloub, Hazem Abosheaishaa, Khaled Elfert, Arpit Sharma, Sherif Andrawes, Nikki Duong   +7 more
wiley   +1 more source

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol‐Associated Cirrhosis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 12, Page 1673-1684, June 2026.
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo, Sepideh Mehravar, Ellen Choi, Ju Dong Yang, Hyun‐Seok Kim, Yun Wang, Aarshi Vipani, Hirsh D. Trivedi, Walid Ayoub, Parnian Naji, Alexander Kuo, Chun‐Ying Wu, Lorenzo Leggio, Juan Pablo Arab   +13 more
wiley   +1 more source

Long‐Term Outcomes After Endoscopic Resection for Strictly Defined Ulcerative Colitis‐Associated Neoplasia: An Exploratory Retrospective Cohort Study

Digestive Endoscopy, Volume 38, Issue 6, June 2026.
ABSTRACT Objectives Ulcerative colitis (UC)‐associated neoplasia (UCAN) carries a risk of metachronous development; however, risk stratification based on inflammatory origin remains unclear. This exploratory study aimed to classify UCAN arising in colitis‐affected areas and to evaluate long‐term outcomes after endoscopic resection (ER).
Masafumi Nishio, Kingo Hirasawa, Sawako Chiba, Yuriko Takeda, Mizuki Tatsuno, Kimio Nozaki, Keita Morohashi, Tomoki Kanemura, Reo Atsusaka, Daisuke Azuma, Atsushi Sawada, Ryosuke Kobayashi, Chiko Sato, Tsuyoshi Ogashiwa, Reiko Kunisaki, Hideaki Kimura, Shin Maeda   +16 more
wiley   +1 more source

Beyond the Graft: Optimizing Post-Transplant Care in Primary Sclerosing Cholangitis. [PDF]

J Clin Med
Becchetti C, Viganò R, Aprile F, Scaravaglio M, Vitale G, Perricone G, Mazzarelli C, Vangeli M, Belli LS, Carbone M, Morelli MC.   +10 more
europepmc   +1 more source

Case study — primary sclerosing cholangitis

, 2012
Mortimore, Gerri
core   +1 more source

Cholangiocarcinoma in primary sclerosing cholangitis

, 2001
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown causes closely associated with ulcerative colitis. PSC is a progressive disease leading to liver failure and need for liver transplantation.
Annika Bergquist (243251)
core  

Cardiovascular risk profiles in patients with primary sclerosing cholangitis. [PDF]

Eur J Gastroenterol Hepatol
Sleutjes JAM, van de Pol N, van der Meer AJ, de Man RA, van der Woude CJ, Roeters van Lennep JE, de Vries AC.   +6 more
europepmc   +1 more source

Artificial Intelligence Applications in Body MRI: Opportunities and Limitations

Journal of Magnetic Resonance Imaging, Volume 63, Issue 6, Page 1713-1714, June 2026.
Haresh Naringrekar, Abdullah Alturki
wiley   +1 more source

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1701-1721, June 2026.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source

Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern? [PDF]

Clin Transl Gastroenterol
Cardinale V, Ridola L, Alvaro D.
europepmc   +1 more source